newsfilter
← Latest News
GlobeNewswire·

RVL Pharmaceuticals plc Reports Third Quarter 2022 Financial Results; Provides Commercial Update

-- Third quarter 2022 UPNEEQ® net product sales of $10.0 million; 19% above second quarter 2022; 355% above third quarter 2021 -- -- Approximately 3,500 cumulative unique medical aesthetics practices placed